The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in Virus Research
- Vol. 286, 198074
- https://doi.org/10.1016/j.virusres.2020.198074
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32041001, 81902070)
- Natural Science Foundation of Hunan Province (2019JJ20004, 2019JJ50035, 2020SK3001)
This publication has 12 references indexed in Scilit:
- Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in MacrophagesJournal of Virology, 2020
- Department of ErrorThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Coronavirus Endoribonuclease Activity in Porcine Epidemic Diarrhea Virus Suppresses Type I and Type III Interferon ResponsesJournal of Virology, 2019
- Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmissionScientific Reports, 2018
- Combination Attenuation Offers Strategy for Live Attenuated Coronavirus VaccinesJournal of Virology, 2018
- Genome-wide identification of interferon-sensitive mutations enables influenza vaccine designScience, 2018
- MERS-CoV Accessory ORFs Play Key Role for Infection and PathogenesismBio, 2017
- The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I InterferonCell Host & Microbe, 2014
- Type 1 Interferons and the Virus-Host Relationship: A Lesson in DétenteScience, 2006